These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Lee SE; Kim JM; Jeong SK; Jeon JE; Yoon HJ; Jeong MK; Lee SH Arch Dermatol Res; 2010 Dec; 302(10):745-56. PubMed ID: 20697725 [TBL] [Abstract][Full Text] [Related]
10. Viaminate ameliorates Propionibacterium acnes-induced acne via inhibition of the TLR2/NF-κB and MAPK pathways in rats. Cao J; Xu M; Zhu L; Xiao S Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1487-1500. PubMed ID: 36757484 [TBL] [Abstract][Full Text] [Related]
11. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290 [TBL] [Abstract][Full Text] [Related]
12. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Kim J Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063 [TBL] [Abstract][Full Text] [Related]
13. The protective effects of melittin on Propionibacterium acnes-induced inflammatory responses in vitro and in vivo. Lee WR; Kim KH; An HJ; Kim JY; Chang YC; Chung H; Park YY; Lee ML; Park KK J Invest Dermatol; 2014 Jul; 134(7):1922-1930. PubMed ID: 24496237 [TBL] [Abstract][Full Text] [Related]
14. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes. Jarrousse V; Castex-Rizzi N; Khammari A; Charveron M; Dréno B Eur J Dermatol; 2007; 17(6):492-6. PubMed ID: 17951128 [TBL] [Abstract][Full Text] [Related]
15. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation. Isard O; Knol AC; Ariès MF; Nguyen JM; Khammari A; Castex-Rizzi N; Dréno B J Invest Dermatol; 2011 Jan; 131(1):59-66. PubMed ID: 20927124 [TBL] [Abstract][Full Text] [Related]
16. Propionibacterium acnes-induced iNOS and COX-2 protein expression via ROS-dependent NF-κB and AP-1 activation in macrophages. Tsai HH; Lee WR; Wang PH; Cheng KT; Chen YC; Shen SC J Dermatol Sci; 2013 Feb; 69(2):122-31. PubMed ID: 23178030 [TBL] [Abstract][Full Text] [Related]
17. Cell-free extracts of Propionibacterium acnes stimulate cytokine production through activation of p38 MAPK and Toll-like receptor in SZ95 sebocytes. Huang YC; Yang CH; Li TT; Zouboulis CC; Hsu HC Life Sci; 2015 Oct; 139():123-31. PubMed ID: 26341693 [TBL] [Abstract][Full Text] [Related]
18. Effects of Propionibacterium acnes on various mRNA expression levels in normal human epidermal keratinocytes in vitro. Akaza N; Akamatsu H; Kishi M; Mizutani H; Ishii I; Nakata S; Matsunaga K J Dermatol; 2009 Apr; 36(4):213-23. PubMed ID: 19348660 [TBL] [Abstract][Full Text] [Related]
19. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice. Ryu S; Han HM; Song PI; Armstrong CA; Park Y PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393 [TBL] [Abstract][Full Text] [Related]
20. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes. Lee YJ; Choi HJ; Kang TW; Kim HO; Chung MJ; Park YM J Microbiol Biotechnol; 2008 Jul; 18(7):1308-16. PubMed ID: 18667861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]